Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
COLON: Innovations3 steps, 3 parts…..
Detection: I see an abnormality (usually a polyp)
Characterization: Is this abnormality neoplastic ?(for example: an adenoma)
Treatment: it is neoplastic. Can I treat it using endoscopy ?
COLON: Innovations
Detection
Characterization
Treatment
COLON: Innovations
Detection
Characterization
Treatment
DetectionDetection: innovations: innovations
…………..2 different approaches..2 different approaches
IMAGE QUALITYIMAGE QUALITY
TOLERANCETOLERANCEto improve the pt compliance to to improve the pt compliance to screening (mass screening or screening (mass screening or individual screening)individual screening)
DetectionDetection: innovations: innovations
…………..2 different approaches..2 different approaches
IMAGE QUALITYIMAGE QUALITY
TOLERANCETOLERANCEto improve the pt compliance to to improve the pt compliance to screening (mass screening or screening (mass screening or individual screening)individual screening)
How to improve How to improve patient tolerance ?patient tolerance ?
New colonoscopesNew colonoscopes= mechanical part of the endoscope has = mechanical part of the endoscope has been modifiedbeen modifiedto facilitate insertion (and visualization)to facilitate insertion (and visualization)
11-- AerAer--OO--scopescope22-- ColonosightColonosight33-- InvendoInvendo44-- EthiconEthicon55-- NeoguideNeoguide66-- ShapelockShapelock77-- Spiral overtubeSpiral overtube88-- VideocapsuleVideocapsule
Is it possible to classify them ?Is it possible to classify them ?
We must take into account We must take into account the mass screening process:the mass screening process:How is mass screening organized ?How is mass screening organized ?
Mass screening of CRCMass screening of CRC= 2 tests= 2 tests
first test: FOBT, first test: FOBT, …………
second test: colonoscopysecond test: colonoscopyif first test positiveif first test positive
Some could replace the first test Some could replace the first test EthiconEthiconAerAer--OO--scopescopeCapsuleCapsule
because they have no therapeutic capabilities (no because they have no therapeutic capabilities (no operating channel)operating channel)
Some could replace the second test: Some could replace the second test: InvendoInvendoNeoguideNeoguideColonosight Colonosight
Overtube: Overtube: ShapelockShapelockSpiral overtube Spiral overtube
Abandoned
Some could replace the first test Some could replace the first test EthiconEthiconAerAer--OO--scopescopeCapsuleCapsule
because they have no therapeutic capabilities (no because they have no therapeutic capabilities (no operating channel)operating channel)
Some could replace the second test: Some could replace the second test: InvendoInvendoNeoguideNeoguideColonosight Colonosight
Overtube: Overtube: ShapelockShapelockSpiral overtube Spiral overtube
Vucelic Gastroenterology 2006:10 caecal intubations /12
Almost abandoned
Some could replace the first test Some could replace the first test EthiconEthiconAerAer--OO--scopescopeCapsuleCapsule
because they have no therapeutic capabilities (no because they have no therapeutic capabilities (no operating channel)operating channel)
Some could replace the second test: Some could replace the second test: InvendoInvendoNeoguideNeoguideColonosight Colonosight
Overtube: Overtube: ShapelockShapelockSpiral overtube Spiral overtube
European study320 pts
All polyps >6mm >10mm
Sensitivity 73% 64% 60%Specificity 77% 84% 98%PPV 86% 60% 83%NPV 59% 86% 93%
Bowel cleansing: grade good and above
Capsule Colo
Total 72% 87%Sigmoid 70% 87%Descending 77% 86%Transverse 74% 86%Ascending 69% 83%Caecum 61% 81%
Some could replace the first test Some could replace the first test EthiconEthiconAerAer--OO--scopescopeCapsuleCapsule
because they have no therapeutic capabilities (no because they have no therapeutic capabilities (no operating channel)operating channel)
Some could replace the second test: Some could replace the second test: InvendoInvendoNeoguideNeoguideColonosight Colonosight
Overtube: Overtube: ShapelockShapelockSpiral overtube Spiral overtube
LEDOperating channel
Remote control
Single-usecolonoscope
Pneumaticbending
Rösch GIE 200834 patients82% caecal intubation
LEDOperating channel
Remote control
Single-usecolonoscope
Pneumaticbending
Uncertain future
Some could replace the first test Some could replace the first test EthiconEthiconAerAer--OO--scopescopeCapsuleCapsule
because they have no therapeutic capabilities (no because they have no therapeutic capabilities (no operating channel)operating channel)
Some could replace the second test: Some could replace the second test: InvendoInvendoNeoguideNeoguideColonosight Colonosight
Overtube: Overtube: ShapelockShapelockSpiral overtube Spiral overtube
NeoGuide Endoscopy System
AbandonedDevelopment for« NOTES »
EickhoffAm J Gastro 200710 caecal intubations / 11
Some could replace the first test Some could replace the first test EthiconEthiconAerAer--OO--scopescopeCapsuleCapsule
because they have no therapeutic capabilities (no because they have no therapeutic capabilities (no operating channel)operating channel)
Some could replace the second test: Some could replace the second test: InvendoInvendoNeoguideNeoguideColonosight Colonosight -- STRYKER STRYKER
Overtube: Overtube: ShapelockShapelockSpiral overtube Spiral overtube
Pneumatic propellerLEDSingle use sheath
Almost AbandonedOnly focused on single use sheath
Improving pt toleranceImproving pt tolerancenew colonoscopes: new colonoscopes: ConclusionConclusion
Very disappointingVery disappointing
Capsule: almost the last productCapsule: almost the last productMain problem with capsule = bowel Main problem with capsule = bowel cleansingcleansing
DetectionDetection: innovations: innovations
…………..2 different approaches..2 different approaches
IMAGE QUALITYIMAGE QUALITY
TOLERANCETOLERANCEto improve the pt compliance to to improve the pt compliance to screening (mass screening or screening (mass screening or individual screening)individual screening)
IMAGE QUALITY : innovationsIMAGE QUALITY : innovations
Virtual chromoscopyVirtual chromoscopy
AutofluorescenceAutofluorescence
Image enlargementImage enlargement
IMAGE QUALITY : innovationsIMAGE QUALITY : innovations
Virtual chromoscopyVirtual chromoscopy
AutofluorescenceAutofluorescence
Image enlargementImage enlargement
White light
NBI
Narrow band imaging Spectrum
Adenoma Detection
Adenoma detection - Randomised
65
23
72
51
67
17
60
44
01020304050607080
Rex Adler East Kalten-bach
% w
ith 1
+ ad
enom
as
NBI
WhiteLight
Rex D et al GIE 2006Rex D et al GIE 2006Adler A Adler A et al.et al. Gut 08 Gut 08 East JE East JE et al.et al. DDW 07DDW 07Kaltenbach TR Kaltenbach TR et al.et al. DDW 07DDW 07
Inoue T J Gastro 2008: 243 pts, No effect
HNPCC
Proportion flat adenomas
12%
45%
0%
10%
20%
30%
40%
50%
Prop
ortio
n fla
t ade
nom
as
White lightNBI
P=.039/21
3/25
Adenoma detection - proximal colon
27%
42%
0%5%
10%15%20%25%30%35%40%45%
At l
east
one
ade
nom
a
White lightWL + NBI
P=.004
East JE East JE et al.et al.Gut 08Gut 08
NBI
NBI
WL
Detection DALMs in ColitisNBI can detect and characterise DALMsNot better than white light
East East et al.et al. Gut 2006;55:1432Gut 2006;55:1432--3535Dekker Dekker et al.et al. Endoscopy 2007;39:216Endoscopy 2007;39:216--2121
NBI: detection
Average risk populationIs virtual chromoendoscopy recommended as the standard for CCR screening ? No.
High risk population: HNPCCCan NBI replace chromoendoscopy? PossiblyYes
High risk population: UC surveillanceCan NBI replace chromoendoscopy ? No
Fujinon Intelligent Colour Enhancement (FICE) ?
• Patients presenting for routine colonoscopy were randomly assigned to FICE or white light with targeted chromoscopy (indigo carmine).
• 871 pts• Adenomas: 236 FICE vs 271 white light
Pohl et al. DDW 2008
IMAGE QUALITY : innovationsIMAGE QUALITY : innovations
Virtual chromoscopyVirtual chromoscopy
AutofluorescenceAutofluorescence
Image enlargementImage enlargement
Juntendo University
Autofluorescence Autofluorescence ColonColon
AFI
AFI
Matsuda Am J Gastroenterol167 pts, random AFI vs WL+ 34% adenomas
HoweverSome disappointements
IMAGE QUALITY : innovationsIMAGE QUALITY : innovations
Virtual chromoscopyVirtual chromoscopy
AutofluorescenceAutofluorescence
Image enlargementImage enlargement
= To better see behind the folds
Wide angle colonoscope Wide angle colonoscope
standard 140standard 140°°
210210°
Rex Am J Gastro 2003Rex Am J Gastro 2003Deenadayalu Am J Gastro 2004Deenadayalu Am J Gastro 2004
Pb = No effect on miss ratesPb = No effect on miss rates
Third eye
Third eye: pilot study
100 pts
+ 17.6% polyps+ 12.3% adenomas
Waye GIE 2008 AB101
Image quality: ConclusionImage quality: Conclusion
NBI and FICE: limited roleNBI and FICE: limited role
Autofluorescence: uncertainAutofluorescence: uncertain
Image enlargement: interesting field but Image enlargement: interesting field but japanese companies not so interestedjapanese companies not so interestedWhy ?Why ?
COLON: Innovations
Detection
Characterization
Treatment
Can we replace biopsies ?
Can we let in place a polyp ?
Can we orientate the management (IBD ?)
CHARACTERIZATION : innovationsCHARACTERIZATION : innovations
Virtual chromoscopyVirtual chromoscopy
EndocystoscopyEndocystoscopy
Confocal microscopyConfocal microscopy
NBI: pit pattern (such as for chromoscopy)
Hirata , GIE 2007
Hyperplastic Adenoma Carcinoma
NBI can also permit to analyze the vascular pattern ......(not possible with chromo)
NBI: vascular patternHyperplasticWeak vascularpattern
Adenoma: strong vascular pattern
Polyp number
Sensitivity Specificity
Chiu Gut 2007* 180 87-95 % 72-88 %Su Am J Gastro 2006*† 110 96 88Hirata GIE 2007 100 99 94Machida Endoscopy 2004 43 100 75East GIE 2007 33 77-91 50-60Tischendorf Endosc 2007 200 90-94 89-89
NBI: Adenoma vs hyperplastic polyp?NBI: Adenoma vs hyperplastic polyp?
From all these data concerning NBI, From all these data concerning NBI,
If we say type II = hyperplastic polyp,If we say type II = hyperplastic polyp,we have we have 6%6% of risk that the polyp is adenomatousof risk that the polyp is adenomatous
If we say type III = adenomatous polyp,If we say type III = adenomatous polyp,we have we have 16%16% of risk that the polyp is hyperplasticof risk that the polyp is hyperplastic
chromoendochromoendo NBINBI
Risk to miss adenomaRisk to miss adenoma 13%13% 6%6%Risk to miss hyperplastic.Risk to miss hyperplastic. 25%25% 16%16%
CHARACTERIZATION : innovationsCHARACTERIZATION : innovations
Virtual chromoscopyVirtual chromoscopy
EndocystoscopyEndocystoscopy
Confocal microscopyConfocal microscopy
Endocytoscopy system ×450Background mucosa
Endocytoscopy system ×450Cancer
CHARACTERIZATION : innovationsCHARACTERIZATION : innovations
Virtual chromoscopyVirtual chromoscopy
EndocystoscopyEndocystoscopy
Confocal microscopyConfocal microscopy
Light Guide
Confocal Imaging Window
Biopsy Channel
CCD
Light Guide
Air/Water Nozzles
Auxiliary WaterJet Channel
Confocal microscopyConfocal microscopy
Ileum
Kiesslich
Hyperplasia
Kiesslich
Adenoma
Kiesslich
Colonic cancer
Kiesslich
Cancer in-situ
Kiesslich
Mild UC
Kiesslich
Severe UC
Kiesslich
Kiesslich Gastroenterol 2007Kiesslich Gastroenterol 2007
Diagnosis of neoplastic changes on IBDDiagnosis of neoplastic changes on IBDAccuracy = 97.8%Accuracy = 97.8%10 fold reduction of the number of biopsies10 fold reduction of the number of biopsies
Hurstone Clin Gastroenterol Hepatol 07, Gut 08Hurstone Clin Gastroenterol Hepatol 07, Gut 08
Kappa coefficient of agreement between endomicroscopy and histopathology: 0.91 Accuracy: 97%2.5 fold increase of the dg yield / chromoscopy
Characterization: ConclusionCharacterization: Conclusion
NBI :NBI : promising to characterize polypspromising to characterize polypsbut is it helpful ? (ex: serrated adenomas)but is it helpful ? (ex: serrated adenomas)
Endomicroscopy:Endomicroscopy: to be evaluatedto be evaluated
Confocal microscopy:Confocal microscopy:Very effective in IBD in expert handsVery effective in IBD in expert handsBut needs confirmation in routine But needs confirmation in routine
COLON: Innovations
Detection
Characterization
Treatment
Last advance = Endoscopic submucosal dissection(ESD)
IT knife Needle knife
Flex knife Hook knife
En bloc resection 97.7% (209/214)Curative resection 89.7% (192/214)
Perforation 7.0% (15/214)0.9% (2/214): surgDelayed Perforation3.7% (8/214)Delayed bleeding
Results of Colorectal ESD
Apr. 2005-Jan.2008, Toranomon Hospital
0% (0/214)Local recurrence
RESULTSRESULTS OF ESDNbr en-bloc R0 Perf CR
TANAKA 70 80% 10% 100%GIE 07 FUJISHIRO 35 88% 63% 6% 100%GIE 06TAMAGAI 105 99% 1%UEGW07Lyon 16 75% 44% 12%
Do we all need to learn and perform ESD for colorectal adenomas ?
Main advantage of ESD
= resection is aiming R0
AdenomaAdenoma
Aiming R0 Not aiming R0
AdenomaAdenoma
Fragments = pieceFragments = piece--mealmealNot aiming R0Not aiming R0
Aiming R0Aiming R0
piece-meal
Which are the 2 consequences to do not get a R0 resection ?
1- Risk of « recurrence » = 30%Rate increased
with diameterwith piece-meal in comparison to one piece
Kaltenbach GIE 07, Hurlstone Gut 04, Tamura Endosc 04, Tanaka GIE01, Su AJG 05, Sano Dig Endosc 04
FOLLOW-UP to be organized
Balance
Perforation riskProcedure duration Need for follow-up
Looking for perfection is maybe not the more cost-effective approach……
Which are the 2 consequences to let in place adenomatous tissue ?
2- Risk to let in place or to have destroyed carcinoma
AdenomaAdenoma
Invasive carInvasive car
FragmentsFragments
AdenomaAdenoma
Invasive carInvasive car
In which cases do we need to aim to have a R0 resection ?
2 CLASSIFICATIONS to be known
Paris classificationmacroscopy, general pattern
Kudo classificationmacroscopy, pitt pattern
Polypoïd
Flat
Ulcerated
0-Ip 0-Issessilepedunculated
surelevated flat depressed0-IIa 0-IIb 0-IIc
0-III
IIc + IIa IIa + IIc
Complex patterns
LST = Is + IIc
II a + II c
II c + II a
0
20
40
60
80
100
120
0-I 0-II a 0-II b 0-II c III
Oeso
Stomach
Colon
Submucosal invasion
2 CLASSIFICATIONS to be known
Paris classificationmacroscopy, general pattern
Kudo classificationmacroscopy, pitt pattern
IIILIIIS IV
Small tubularSmall tubular large tubularlarge tubular branchedbranched
adenoma
VI VN
irregularirregular Non structuredNon structured
carcinoma
In which cases do we need to aim to have a R0 resection ?
Ulcerated0-III
Reference = surgery
Endoscopyonly if aiming R0
If Kudo type VReference = surgeryEndoscopy only if aiming R0
0-IIc
IIc + IIa
IIa + IIcLST = Is + IIc
II a + II c
II c + II a
Treatment: conclusion on ESD
Adenoma = cost-effectiveness analyzis is requiredSuspicion of invasive adenocar = ESD to be recommended (Kudo V, depressed or complex Paris)
At least, excellent technique to improve material and skillfulness
GENERAL CONCLUSION
Numerous innovationsDifferent aims: needs to be classified (detection, characterization)
Frequently disappointing
Will not replace good practice (ex: adenoma detection rate, biopsies, EMR)